These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 27704245)

  • 21. Early proactive management of vestibular schwannomas in neurofibromatosis type 2.
    Brackmann DE; Fayad JN; Slattery WH; Friedman RA; Day JD; Hitselberger WE; Owens RM
    Neurosurgery; 2001 Aug; 49(2):274-80; discussion 280-3. PubMed ID: 11504103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes of cochlear implantation in patients with neurofibromatosis type 2.
    North HJ; Mawman D; O'Driscoll M; Freeman SR; Rutherford SA; King AT; Hammerbeck-Ward C; Evans DG; Lloyd SK
    Cochlear Implants Int; 2016 Jul; 17(4):172-177. PubMed ID: 27691934
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Audiovestibular Characteristics of Small Cochleovestibular Schwannomas in Neurofibromatosis Type 2.
    Holliday MA; Kim HJ; Zalewski CK; Wafa T; Dewan R; King KA; Brewer CC; Butman JA; Asthagiri AR
    Otolaryngol Head Neck Surg; 2014 Jul; 151(1):117-24. PubMed ID: 24718755
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Auditory brainstem implants in NF2 patients: results and review of the literature.
    Sanna M; Di Lella F; Guida M; Merkus P
    Otol Neurotol; 2012 Feb; 33(2):154-64. PubMed ID: 22246383
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A clinical study of vestibular schwannomas in type 2 neurofibromatosis.
    Kishore A; O'Reilly BF
    Clin Otolaryngol Allied Sci; 2000 Dec; 25(6):561-5. PubMed ID: 11122300
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ipsilateral Cochlear Implantation in the Presence of Observed and Irradiated Vestibular Schwannomas.
    Urban MJ; Moore DM; Kwarta K; Leonetti J; Rajasekhar R; Gluth MB; Wiet RM
    Ann Otol Rhinol Laryngol; 2020 Dec; 129(12):1229-1238. PubMed ID: 32551844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcome from surgery for vestibular schwannomas in children.
    MacNally SP; Rutherford SA; King AT; Freeman S; Thorne J; Mawman D; O'Driscoll MP; Evans DG; Ramsden RT
    Br J Neurosurg; 2009 Jun; 23(3):226-31. PubMed ID: 19533454
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hearing changes after diagnosis in neurofibromatosis type 2.
    Masuda A; Fisher LM; Oppenheimer ML; Iqbal Z; Slattery WH;
    Otol Neurotol; 2004 Mar; 25(2):150-4. PubMed ID: 15021775
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ipsilateral cochlear implantation after cochlear nerve preserving vestibular schwannoma surgery in patients with neurofibromatosis type 2.
    Lloyd SK; Glynn FJ; Rutherford SA; King AT; Mawman DJ; O'Driscoll MP; Evans DG; Ramsden RT; Freeman SR
    Otol Neurotol; 2014 Jan; 35(1):43-51. PubMed ID: 24335931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cochlear implants to treat deafness caused by vestibular schwannomas.
    Mukherjee P; Ramsden JD; Donnelly N; Axon P; Saeed S; Fagan P; Irving RM
    Otol Neurotol; 2013 Sep; 34(7):1291-8. PubMed ID: 23921933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cochlear implantation in patients with neurofibromatosis type 2: variables affecting auditory performance.
    Carlson ML; Breen JT; Driscoll CL; Link MJ; Neff BA; Gifford RH; Beatty CW
    Otol Neurotol; 2012 Jul; 33(5):853-62. PubMed ID: 22664900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hearing preservation in neurofibromatosis type 2.
    Slattery WH; Brackmann DE; Hitselberger W
    Am J Otol; 1998 Sep; 19(5):638-43. PubMed ID: 9752973
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bevacizumab decreases vestibular schwannomas growth rate in children and teenagers with neurofibromatosis type 2.
    Hochart A; Gaillard V; Baroncini M; André N; Vannier JP; Vinchon M; Dubrulle F; Lejeune JP; Vincent C; Nève V; Sudour Bonnange H; Bonne NX; Leblond P
    J Neurooncol; 2015 Sep; 124(2):229-36. PubMed ID: 26022982
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurofibromatosis type 2: Hearing preservation and rehabilitation.
    Jia H; El Sayed MME; Smail M; Mosnier I; Wu H; Sterkers O; Kalamarides M; Bernardeschi D
    Neurochirurgie; 2018 Nov; 64(5):348-354. PubMed ID: 30314805
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Systematic Review of Radiosurgery Versus Surgery for Neurofibromatosis Type 2 Vestibular Schwannomas.
    Chung LK; Nguyen TP; Sheppard JP; Lagman C; Tenn S; Lee P; Kaprealian T; Chin R; Gopen Q; Yang I
    World Neurosurg; 2018 Jan; 109():47-58. PubMed ID: 28882713
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hearing preservation with the middle cranial fossa approach for neurofibromatosis type 2.
    Friedman RA; Goddard JC; Wilkinson EP; Schwartz MS; Slattery WH; Fayad JN; Brackmann DE
    Otol Neurotol; 2011 Dec; 32(9):1530-7. PubMed ID: 21986931
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Diagnosis and Management of Vestibular Schwannomas - An Interdisciplinary Challenge].
    Rosahl S; Bohr C; Lell M; Hamm K; Iro H
    Laryngorhinootologie; 2017 Apr; 96(S 01):S152-S182. PubMed ID: 29036751
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microsurgery for patients diagnosed with neurofibromatosis type 2 complicated by vestibular schwannomas: Clinical experience and strategy for treatments.
    Chen LH; Zhang HT; Xu RX; Zhang L; Li WD; Sun K
    Medicine (Baltimore); 2018 Apr; 97(17):e0270. PubMed ID: 29702972
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gamma Knife radiosurgery for vestibular schwannoma: clinical results at long-term follow-up in a series of 379 patients.
    Boari N; Bailo M; Gagliardi F; Franzin A; Gemma M; del Vecchio A; Bolognesi A; Picozzi P; Mortini P
    J Neurosurg; 2014 Dec; 121 Suppl():123-42. PubMed ID: 25434946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcome of translabyrinthine surgery for vestibular schwannoma in neurofibromatosis type 2.
    Moffat DA; Lloyd SK; Macfarlane R; Mannion R; King A; Rutherford S; Axon PR; Donnelly N; Freeman S; Tysome JR; Evans DG; Ramsden RT
    Br J Neurosurg; 2013 Aug; 27(4):446-53. PubMed ID: 23472624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.